State of New Jersey Common Pension Fund D’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-64,300
Closed -$2M 1698
2022
Q2
$2M Buy
64,300
+4,457
+7% +$152K 0.01% 1510
2022
Q1
$2.46M Sell
59,843
-10,250
-15% -$452K 0.01% 1402
2021
Q4
$3.05M Buy
70,093
+26,967
+63% +$1.22M 0.01% 1054
2021
Q3
$2.16M Buy
43,126
+428
+1% +$25.9K 0.01% 1659
2021
Q2
$2.69M Buy
42,698
+14,609
+52% +$939K 0.01% 1225
2021
Q1
$2.61M Sell
28,089
-1,713
-6% -$175K 0.01% 1239
2020
Q4
$2.67M Sell
29,802
-1,177
-4% -$108K 0.01% 1226
2020
Q3
$3.2M Sell
30,979
-2,218
-7% -$239K 0.01% 847
2020
Q2
$2.63M Sell
33,197
-6,968
-17% -$519K 0.01% 979
2020
Q1
$2.32M Hold
40,165
0.01% 916
2019
Q4
$2.17M Sell
40,165
-13,035
-25% -$707K 0.01% 1427
2019
Q3
$2.78M Buy
+53,200
New +$2.48M 0.01% 1080

Other funds holding EBS

State of New Jersey Common Pension Fund D's EBS Position: Q3 2022 in Review

State of New Jersey Common Pension Fund D sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 64,300 shares — an estimated $2M sold.

State of New Jersey Common Pension Fund D first reported a position in EBS in Q3 2019 and held it in 12 quarters. The position peaked at $3.2M in Q3 2020. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • State of New Jersey Common Pension Fund D reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 64,300 Emergent Biosolutions shares in Q3 2022, an estimated $2M.
  • State of New Jersey Common Pension Fund D first reported a position in Emergent Biosolutions in Q3 2019 and held it in 12 quarters.
  • State of New Jersey Common Pension Fund D's Emergent Biosolutions position peaked at $3.2M in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2022, filed 28 Oct 2022.